H. Fujihara et al., INHIBITION OF RHOA TRANSLOCATION AND CALCIUM SENSITIZATION BY IN-VIVOADP-RIBOSYLATION WITH THE CHIMERIC TOXIN DC3B, Molecular biology of the cell, 8(12), 1997, pp. 2437-2447
Pretreatment of intact rabbit portal vein smooth muscle with the chime
ric toxin DC3B (10(-6) M, 48 h; Aullo et al., 1993; Boquet et al. 1995
) ADP-ribosylated endogenous RhoA, including cytosolic RhoA complexed
with rhoGDI, and inhibited the tonic phase of phenylephrine-induced co
ntraction and the Ca2+-sensitization of force by phenylephrine, endoth
elin and guanosine triphosphate (GTP)gamma S, but did not inhibit Ca2-sensitization by phorbol dibutyrate. DC3B also inhibited GTP gamma S-
induced translocation of cytosolic RhoA (Gong et al., 1997a) to the me
mbrane fraction. In DC3B-treated muscles the small fraction of membran
e-associated RhoA could be immunoprecipitated, even after exposure to
GTP gamma S, which prevents immunoprecipitation of non-ADP-ribosylated
RhoA. Dissociation of cytosolic RhoA-rhoGDI complexes with SDS restor
ed the immunoprecipitability and ADP ribosylatability: of RhoA, indica
ting that both the ADP-ribosylation site (Asn 41) and RhoA insert loop
(Wei et al., 1997) are masked by rhoGDI and that the long axes of the
two proteins are in parallel in the heterodimer. We conclude that Rho
A plays a significant role in G-protein-, but not protein kinase C-med
iated, Ca2+ sensitization and that ADP ribosylation inhibits in vivo t
he Ca2+-sensitizing effect of RhoA by interfering with its binding to
a membrane-associated effector.